Med Solutions, LLC

Med Solutions, LLC was paid $757K by Medicaid between Jan 2018 and Jul 2024, across 62 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 74% of everything it billed.

33Billing provider infoMED SOLUTIONS, LLC
WEST PATERSON, NJ 07424

33aNPI1972652634assigned 01/10/2007

33bProvider typePulmonary Disease Physician

28Total paid$757K

24GClaims37,124

24DCodes billed62

24AFirst – last monthJan 2018 – Jul 2024

Compared with peers

Next to other Pulmonary Disease Physician providers in New Jersey

Rank by total paid#7 of 112

Median peer was paid$24K

This provider vs. median31×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	3,535	$132K
2019	3,674	$112K
2020	4,890	$133K
2021	6,774	$97K
2022	10,196	$112K
2023	5,557	$112K
2024incomplete	2,498	$59K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	74%	14,457	11,575	$562K
99457		4.8%	2,495	2,283	$36K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	2.6%	219	219	$20K
99490	Ccm add 20min	2.4%	1,422	1,362	$18K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	2.1%	356	284	$16K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	1.8%	524	447	$13K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.5%	332	303	$11K
94644		1.1%	453	299	$9K
20611		1.1%	296	258	$8K
95912		<1%	63	63	$7K
94660		<1%	417	383	$7K
94060		<1%	308	298	$7K

50 more codes

94729		<1%	285	$6K
94726		<1%	286	$6K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	170	$4K
96415		<1%	332	$4K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	145	$4K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	542	$2K
96367		<1%	173	$2K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	127	$2K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	80	$2K
92512		<1%	60	$1K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	266	$1K
G0447	Face-to-face behavioral counseling for obesity, 15 minutes	<1%	316	$1K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	994	$869.65
94375		<1%	128	$661.67
94010		<1%	129	$572.08
94200		<1%	86	$534.32
93000		<1%	65	$468.79
G0008	Administration of influenza virus vaccine	<1%	67	$369.28
1125F		<1%	3,165	$173.00
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	303	$159.10
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	303	$156.02
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	<1%	14	$148.04
Q2037	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)	<1%	13	$113.20
99439		<1%	14	$100.86
90674		<1%	22	$93.00
99497		<1%	14	$86.72
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	57	$86.69
94150		<1%	65	$74.06
J1956	Injection, levofloxacin, 250 mg	<1%	27	$40.23
90688		<1%	17	$31.86
G0446	Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes	<1%	15	$14.35
G0442	Annual alcohol misuse screening, 5 to 15 minutes	<1%	15	$10.68
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	64	$4.20
G8420	Bmi is documented within normal parameters and no follow-up plan is required	0%	955	$0.00
2000F		0%	621	$0.00
1036F		0%	2,444	$0.00
1126F		0%	82	$0.00
3080F		0%	88	$0.00
1123F		0%	14	$0.00
G8754	Most recent diastolic blood pressure < 90 mmhg	0%	459	$0.00
1170F		0%	45	$0.00
G8417	Bmi is documented above normal parameters and a follow-up plan is documented	0%	855	$0.00
3077F		0%	519	$0.00
G8752	Most recent systolic blood pressure < 140 mmhg	0%	1,255	$0.00
G0444	Annual depression screening, 5 to 15 minutes	0%	15	$0.00
J1745	Injection, infliximab, excludes biosimilar, 10 mg	0%	15	$0.00
3288F		0%	14	$0.00
1100F		0%	14	$0.00
G8842	Apnea hypopnea index (ahi), respiratory disturbance index (rdi) or respiratory event index (rei) documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea	0%	14	$0.00
0518F		0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCHATTERJEE, DEELIP (PARTNER)